These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10360318)

  • 1. High-frequency transduction (HFT) of resistance to ceftazidime and other antibiotics by a wild-type Pseudomonas aeruginosa phage.
    Blahová J; Králiková K; Krcméry V; Mikovicová A
    Zentralbl Bakteriol; 1999 Apr; 289(2):179-83. PubMed ID: 10360318
    [No Abstract]   [Full Text] [Related]  

  • 2. Transduction of resistance to Imipenem, Aztreonam and Ceftazidime in nosocomial strains of Pseudomonas aeruginosa by wild-type phages.
    Blahová J; Hupková M; Babálová M; Krcméry V; Schäfer V
    Acta Virol; 1993 Dec; 37(6):429-36. PubMed ID: 8010181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two high-frequency-transduction phage isolates from lysogenic strains of Pseudomonas aeruginosa transducing antibiotic resistance.
    Blahová J; Králiková K; Krcméry V; Mikovicová A; Bartoníková N
    Acta Virol; 1998 Jun; 42(3):175-9. PubMed ID: 9842447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transduction of antibiotic resistance in Pseudomomas aeruginosa: relationship between lytic and transducing activity of phage isolate AP-423.
    Blahová J; Králiková K; Krcméry V; Jezek P
    Acta Virol; 1999 Dec; 43(6):395-8. PubMed ID: 10825931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa.
    Uchiyama J; Shigehisa R; Nasukawa T; Mizukami K; Takemura-Uchiyama I; Ujihara T; Murakami H; Imanishi I; Nishifuji K; Sakaguchi M; Matsuzaki S
    Arch Virol; 2018 Jul; 163(7):1941-1948. PubMed ID: 29550930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-frequency transduction of antibiotic resistance in Pseudomonas aeruginosa by a wild-type bacteriophage with restricted specificity for recipient strains.
    Blahová J; Králiková K; Krcméry V; Bartoníková N
    Eur J Clin Microbiol Infect Dis; 1999 Feb; 18(2):152-4. PubMed ID: 10219584
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-Frequency transduction of imipenem resistance and high-frequency transduction of ceftazidime and aztreonam resistance by the bacteriophage AP-151 isolated from a Pseudomonas aeruginosa strain.
    Blahová J; Králiková K; Krcméry V; Jezek P
    J Chemother; 2000 Dec; 12(6):482-6. PubMed ID: 11154029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the activity of cephalosporins against Pseudomonas aeruginosa.
    Bauernfeind A
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():111-7. PubMed ID: 19810172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transduction of antibiotic resistance including imipenem resistance by wild type phages from nosocomial strains of Pseudomonas aeruginosa.
    Blahová J; Králiková K; Krcméry V; Mlynarcík D; Trupl J
    Acta Virol; 1997 Oct; 41(5):293-6. PubMed ID: 9607084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the in-vitro activities of ceftazidime and new cephalosporins against 107 strains of Pseudomonas aeruginosa and 249 strains of cefazolin-resistant Enterobacteriaceae.
    Thabaut A; Durosoir JL; Saliou P
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():123-5. PubMed ID: 19810174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa.
    Aubert D; Poirel L; Chevalier J; Leotard S; Pages JM; Nordmann P
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1615-20. PubMed ID: 11353602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime resistance in Pseudomonas aeruginosa: transduction by a wild-type phage.
    Seginková Z; Krcméry V; Knothe H
    J Infect Dis; 1986 Dec; 154(6):1049-50. PubMed ID: 3097161
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfer, by conjugation and transduction, of resistance to ceftazidime and cefotaxime from the same clinical isolate of Pseudomonas aeruginosa.
    Hupková M; Blahová J; Krcméry V
    Zentralbl Bakteriol; 1994 Aug; 281(2):196-200. PubMed ID: 7858347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The patterns and transmissibility of antibiotic resistance among clinical strains of Pseudomonas aeruginosa.
    Palillo ES; Salleh MA
    Microbiol Immunol; 1992; 36(11):1195-200. PubMed ID: 1491621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients.
    Zamudio R; Hijazi K; Joshi C; Aitken E; Oggioni MR; Gould IM
    Int J Antimicrob Agents; 2019 Jun; 53(6):774-780. PubMed ID: 30831233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro bactericidal activity between cefepime and ceftazidime, alone and associated with amikacin, against carbapenem-resistant Pseudomonas aeruginosa strains.
    Bantar C; Di Chiara M; Nicola F; Relloso S; Smayevsky J
    Diagn Microbiol Infect Dis; 2000 May; 37(1):41-4. PubMed ID: 10794939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F; Quentin C
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates.
    Humphries RM; Hindler JA; Wong-Beringer A; Miller SA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in-vitro activity of three anti-pseudomonal cephalosporins against isolates from patients with cystic fibrosis.
    Kelly N; Falkiner FR; Keane CT; Murphy M; Fitzgerald MX
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():175-8. PubMed ID: 19802982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.